richter's transformation
Showing 1 - 10 of 10
Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Richter's Transformation
- Glofitamab
- +4 more
-
Boston, Massachusetts
- +1 more
Sep 12, 2023
CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)
Recruiting
- CLL
- +9 more
- TG-1801
- Ublituximab
-
Fayetteville, Arkansas
- +4 more
Jan 20, 2023
B-cell Non Hodgkin Lymphoma, Richter's Transformation Trial in United States (Cosibelimab, Cosibelimab + Ublituximab +
Terminated
- B-cell Non Hodgkin Lymphoma
- Richter's Transformation
- Cosibelimab
- Cosibelimab + Ublituximab + Bendamustine combination
-
Huntsville, Alabama
- +8 more
Aug 19, 2022
Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma Trial in United
Recruiting
- Relapsed Chronic Lymphocytic Leukemia
- +4 more
-
Phoenix, Arizona
- +7 more
Apr 28, 2022
Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)
Completed
- Hematopoietic/Lymphoid Cancer
- Richter's Transformation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2022
Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Germany (Obinutuzumab)
Terminated
- Chronic Lymphocytic Leukemia
- Richter's Transformation
- Obinutuzumab
-
Bonn, Germany
- +6 more
Dec 16, 2021
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocyctic Leukemia Trial in Columbus (PCI-32765,
Completed
- B-cell Chronic Lymphocytic Leukemia
- +3 more
-
Columbus, OhioThe Ohio State University
May 28, 2015
Richter's Transformation, Leukemia Trial in Houston (Oxaliplatin, Fludarabine, Cytarabine)
Completed
- Richter's Transformation
- Leukemia
- Oxaliplatin
- +4 more
-
Houston, TexasUT MD Anderson Cancer Center
Nov 1, 2013